Gastric cancer with high risk of intraperitoneal progression: clinical course and current treatments

Gastric cancer with high risk of intraperitoneal progression: clinical course and current treatments

Locally advanced gastric cancer with a high risk of intraperitoneal progression is characterized by poor prognosis. After radical surgery, most patients die during the first two years post-operation as a result of disease progression. The prevailing type of progression and the leading cause of death...

Full description

Bibliographic Details
Main Author: Yarema Roman
Format: Article
Language:English
Published: Sciendo 2017-12-01
Series:Current Issues in Pharmacy and Medical Sciences
Subjects:
gastric cancer
metachronous peritoneal carcinomatosis
hyperthermic intraperitoneal chemotherapy
Online Access:https://doi.org/10.1515/cipms-2017-0036
id doaj-c739f29c3e8144e9b771139ef36a464e
record_format Article
spelling doaj-c739f29c3e8144e9b771139ef36a464e2021-09-06T19:19:39ZengSciendoCurrent Issues in Pharmacy and Medical Sciences2084-980X2300-66762017-12-0130419019410.1515/cipms-2017-0036cipms-2017-0036Gastric cancer with high risk of intraperitoneal progression: clinical course and current treatmentsYarema Roman0Department of Oncology and Medical Radiology, Danylo Halytsky Lviv National Medical University, Pekarska 69, 79010, Lviv, UkraineLocally advanced gastric cancer with a high risk of intraperitoneal progression is characterized by poor prognosis. After radical surgery, most patients die during the first two years post-operation as a result of disease progression. The prevailing type of progression and the leading cause of death in patients with gastric cancer is implantation metastasis.https://doi.org/10.1515/cipms-2017-0036gastric cancermetachronous peritoneal carcinomatosishyperthermic intraperitoneal chemotherapy
collection DOAJ
language English
format Article
sources DOAJ
author Yarema Roman
spellingShingle Yarema Roman
Gastric cancer with high risk of intraperitoneal progression: clinical course and current treatments
Current Issues in Pharmacy and Medical Sciences
gastric cancer
metachronous peritoneal carcinomatosis
hyperthermic intraperitoneal chemotherapy
author_facet Yarema Roman
author_sort Yarema Roman
title Gastric cancer with high risk of intraperitoneal progression: clinical course and current treatments
title_short Gastric cancer with high risk of intraperitoneal progression: clinical course and current treatments
title_full Gastric cancer with high risk of intraperitoneal progression: clinical course and current treatments
title_fullStr Gastric cancer with high risk of intraperitoneal progression: clinical course and current treatments
title_full_unstemmed Gastric cancer with high risk of intraperitoneal progression: clinical course and current treatments
title_sort gastric cancer with high risk of intraperitoneal progression: clinical course and current treatments
publisher Sciendo
series Current Issues in Pharmacy and Medical Sciences
issn 2084-980X
2300-6676
publishDate 2017-12-01
description Locally advanced gastric cancer with a high risk of intraperitoneal progression is characterized by poor prognosis. After radical surgery, most patients die during the first two years post-operation as a result of disease progression. The prevailing type of progression and the leading cause of death in patients with gastric cancer is implantation metastasis.
topic gastric cancer
metachronous peritoneal carcinomatosis
hyperthermic intraperitoneal chemotherapy
url https://doi.org/10.1515/cipms-2017-0036
work_keys_str_mv AT yaremaroman gastriccancerwithhighriskofintraperitonealprogressionclinicalcourseandcurrenttreatments
_version_ 1717778096195633152

Similar Items